Bio Green Med Solution, Inc. (BGMS)
NASDAQ: BGMS · Real-Time Price · USD
1.340
+0.130 (10.74%)
At close: Nov 18, 2025, 4:00 PM EST
1.280
-0.060 (-4.48%)
After-hours: Nov 18, 2025, 5:25 PM EST
Bio Green Med Solution Market Cap
Bio Green Med Solution has a market cap or net worth of $3.94 million as of November 18, 2025. Its market cap has increased by 202.85% in one year.
Market Cap
3.94M
Enterprise Value
104.11K
1-Year Change
202.85%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since May 5, 2004, Bio Green Med Solution's market cap has decreased from $73.90M to $3.94M, a decrease of -94.67%. That is a compound annual growth rate of -12.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 5.90M | 145.83% |
| Dec 31, 2024 | 2.40M | 4.35% |
| Dec 29, 2023 | 2.30M | -72.62% |
| Dec 30, 2022 | 8.40M | -78.35% |
| Dec 31, 2021 | 38.80M | 2.11% |
| Dec 31, 2020 | 38.00M | 230.43% |
| Dec 31, 2019 | 11.50M | 51.32% |
| Dec 31, 2018 | 7.60M | -63.29% |
| Dec 29, 2017 | 20.70M | -8.00% |
| Dec 30, 2016 | 22.50M | 30.06% |
| Dec 31, 2015 | 17.30M | 6.13% |
| Dec 31, 2014 | 16.30M | -78.66% |
| Dec 31, 2013 | 76.40M | 45.80% |
| Dec 31, 2012 | 52.40M | 63.24% |
| Dec 30, 2011 | 32.10M | -54.85% |
| Dec 31, 2010 | 71.10M | 182.14% |
| Dec 31, 2009 | 25.20M | 231.58% |
| Dec 31, 2008 | 7.60M | -92.35% |
| Dec 31, 2007 | 99.40M | -20.16% |
| Dec 29, 2006 | 124.50M | 920.49% |
| Dec 30, 2005 | 12.20M | -75.65% |
| Dec 31, 2004 | 50.10M | -32.21% |
| May 5, 2004 | 73.90M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |